Article
Pulmonary deposition and disappearance of aerosolised secretory leucocyte protease inhibitor.
Thorax - 1 Jun 1995
Stolk J, Camps J, Feitsma H I, Hermans J, Dijkman J H, Pauwels E K
Abstract excerpt
BACKGROUND: The neutrophil elastase inhibitor, secretory leucocyte protease inhibitor (SLPI), is a potential therapeutic tool in inflammatory lung diseases such as cystic fibrosis and pulmonary emphysema. The distribution and disappearance in the lung of aerosolised recombinant SLPI (rSLPI) was investigated in healthy humans and in patients with cystic fibrosis or alpha 1-antitrypsin-associated emphysema....
Topics
- Adult
- Aerosols
- Animals
- Cricetinae
- Cystic Fibrosis
- Half-Life
- Humans
- Lung
- Male
- Mesocricetus
- Phenotype
- Proteinase Inhibitory Proteins, Secretory
